VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
1.870
+0.040 (2.19%)
Mar 9, 2026, 4:00 PM EDT - Market closed
VivoSim Labs Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Market Capitalization | 5 | 4 | 10 | 19 | 33 | 69 | |
| Market Cap Growth | -26.11% | -61.37% | -45.81% | -41.70% | -52.29% | 28.23% | |
| Enterprise Value | 1 | 4 | 7 | 0 | 5 | 50 | |
| Last Close Price | 1.87 | 2.24 | 12.36 | 26.28 | 45.12 | 115.68 | |
| PS Ratio | 34.34 | 27.74 | 94.87 | 51.58 | 21.82 | - | |
| PB Ratio | 1.10 | 0.38 | 2.87 | 1.25 | 1.08 | 1.75 | |
| P/TBV Ratio | 1.10 | 0.38 | 2.88 | 1.25 | 1.09 | 1.76 | |
| EV/Sales Ratio | 9.87 | 28.82 | 60.07 | 0.64 | 3.16 | - | |
| Debt / Equity Ratio | 0.18 | 0.10 | 0.39 | 0.12 | 0.07 | - | |
| Net Debt / Equity Ratio | -0.78 | -0.98 | -0.42 | -0.93 | -0.88 | -0.95 | |
| Net Debt / EBITDA Ratio | 0.31 | 0.83 | 0.10 | 0.81 | 2.34 | 2.67 | |
| Net Debt / FCF Ratio | 0.33 | 1.08 | 0.10 | 1.11 | 2.99 | 2.72 | |
| Asset Turnover | 0.03 | 0.01 | 0.01 | 0.01 | 0.04 | - | |
| Quick Ratio | 1.75 | 3.04 | 1.58 | 4.40 | 20.73 | 51.82 | |
| Current Ratio | 2.44 | 3.25 | 2.12 | 4.64 | 21.35 | 53.26 | |
| Return on Equity (ROE) | -51.07% | -35.31% | -155.00% | -75.80% | -32.99% | -51.12% | |
| Return on Assets (ROA) | -132.52% | -75.10% | -70.73% | -41.34% | -19.60% | -25.63% | |
| Return on Capital Employed (ROCE) | -255.40% | -115.60% | -336.10% | -106.50% | -36.00% | -35.80% | |
| Earnings Yield | -25.16% | -62.28% | -141.87% | -90.43% | -34.97% | -24.52% | |
| FCF Yield | -217.84% | -237.17% | -142.10% | -67.09% | -27.07% | -20.01% | |
| Buyback Yield / Dilution | -84.51% | -92.06% | -4.96% | -0.11% | -26.10% | -6.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.